ClosedBusiness2023 BioMedTech Incubator - Dementia and Cognitive Decline Grant Opportunity

MRFF 2023 BioMedTech Incubator Dementia and Cognitive Decline

Australian Government · Australia

The BioMedTech Incubator – Dementia and Cognitive Decline Grant provides financial assistance to establish an incubator supporting medical research and medical innovation projects. It is intended to fund a single organisation to identify, select and support Australian SMEs developing early-stage dementia and cognitive decline innovations with commercial potential.

Official Grant Page

Funding

Up to $50M

Location

Australia

Who Can Apply

• Must be an eligible organisation • Must be able to establish a working incubator • Incubator must partner with Australian SMEs • Projects supported must focus on early-stage dementia and cognitive decline research and innovation with commercial potential
Applicants must be an eligible organisation capable of establishing a working incubator that partners with Australian SMEs to progress promising early-stage medical research and medical innovation projects focused on dementia and cognitive decline. The opportunity is intended to fund a single organisation under the Medical Research Future Fund and the Medical Research Commercialisation Initiative. Detailed eligibility requirements are contained in the grant opportunity guidelines.

What's Funded

Establishing and operating a BioMedTech incubator that partners with Australian SMEs, identifies and selects promising early-stage dementia and cognitive decline projects, and supports their progression through early development and commercialisation pathways.

Expected Outcomes

A working incubator supporting Australian SMEs and increasing the number of dementia and cognitive decline innovations, including novel drugs, new uses for existing drugs, medical devices and digital health technologies that improve the health and wellbeing of Australians.

Key Information

Applicant Types

companynon_profituniversityother

Stage

established

Funding Purposes

researchinnovationcommercialisation

Keywords

MRFFMedical Research Future FundBioMedTech Incubatordementiacognitive declinemedical researchmedical innovationcommercialisation

Frequently Asked Questions

What is the MRFF 2023 BioMedTech Incubator Dementia and Cognitive Decline?

The MRFF 2023 BioMedTech Incubator Dementia and Cognitive Decline is a business grant offered by Australian Government in Australia, providing Up to $50M in funding. The BioMedTech Incubator – Dementia and Cognitive Decline Grant provides financial assistance to establish an incubator supporting medical research and medical innovation projects. It is intended to fund a single organisation to identify, select and support Australian SMEs developing early-stage dementia and cognitive decline innovations with commercial potential.

How much funding does the MRFF 2023 BioMedTech Incubator Dementia and Cognitive Decline provide?

The MRFF 2023 BioMedTech Incubator Dementia and Cognitive Decline provides Up to $50M in funding.

Who is eligible for the MRFF 2023 BioMedTech Incubator Dementia and Cognitive Decline?

• Must be an eligible organisation • Must be able to establish a working incubator • Incubator must partner with Australian SMEs • Projects supported must focus on early-stage dementia and cognitive decline research and innovation with commercial potential

What activities are funded?

Establishing and operating a BioMedTech incubator that partners with Australian SMEs, identifies and selects promising early-stage dementia and cognitive decline projects, and supports their progression through early development and commercialisation pathways.

How do I apply for the MRFF 2023 BioMedTech Incubator Dementia and Cognitive Decline?

Start by checking your eligibility using the free Beta Docs eligibility checker. If eligible, Beta Docs' AI-powered platform can help you draft, review, and refine your application to maximise your chances of success.

Need help applying?

Beta Docs has helped founders secure $160M+ in competitive grants. Our AI platform drafts compliance-perfect applications — and our expert reviewers make sure you stand out.

Start with Beta DocsBook a free consultation